364 related articles for article (PubMed ID: 21793073)
1. MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.
Glunde K; Jiang L; Moestue SA; Gribbestad IS
NMR Biomed; 2011 Jul; 24(6):673-90. PubMed ID: 21793073
[TBL] [Abstract][Full Text] [Related]
2. Exploiting tumor metabolism for non-invasive imaging of the therapeutic activity of molecularly targeted anticancer agents.
Beloueche-Babari M; Workman P; Leach MO
Cell Cycle; 2011 Sep; 10(17):2883-93. PubMed ID: 21857160
[TBL] [Abstract][Full Text] [Related]
3. MR evaluation of response to targeted treatment in cancer cells.
Podo F; Canevari S; Canese R; Pisanu ME; Ricci A; Iorio E
NMR Biomed; 2011 Jul; 24(6):648-72. PubMed ID: 21387442
[TBL] [Abstract][Full Text] [Related]
4. 17-allyamino-17-demethoxygeldanamycin treatment results in a magnetic resonance spectroscopy-detectable elevation in choline-containing metabolites associated with increased expression of choline transporter SLC44A1 and phospholipase A2.
Brandes AH; Ward CS; Ronen SM
Breast Cancer Res; 2010; 12(5):R84. PubMed ID: 20946630
[TBL] [Abstract][Full Text] [Related]
5. Metabolic tumor imaging using magnetic resonance spectroscopy.
Glunde K; Bhujwalla ZM
Semin Oncol; 2011 Feb; 38(1):26-41. PubMed ID: 21362514
[TBL] [Abstract][Full Text] [Related]
6. Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.
Sonkar K; Ayyappan V; Tressler CM; Adelaja O; Cai R; Cheng M; Glunde K
NMR Biomed; 2019 Oct; 32(10):e4112. PubMed ID: 31184789
[TBL] [Abstract][Full Text] [Related]
7. [1H magnetic resonance spectroscopy of the prostate].
Mueller-Lisse UG; Scherr M
Radiologe; 2003 Jun; 43(6):481-8. PubMed ID: 12827263
[TBL] [Abstract][Full Text] [Related]
8. Cancer metabolism in a snapshot: MRS(I).
Julià-Sapé M; Candiota AP; Arús C
NMR Biomed; 2019 Oct; 32(10):e4054. PubMed ID: 30633389
[TBL] [Abstract][Full Text] [Related]
9. Proton MR spectroscopy of the prostate.
Mueller-Lisse UG; Scherr MK
Eur J Radiol; 2007 Sep; 63(3):351-60. PubMed ID: 17709223
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance spectroscopy of brain tumors].
Ditter P; Hattingen E
Radiologe; 2017 Jun; 57(6):450-458. PubMed ID: 28331947
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance spectroscopic imaging of tumor metabolic markers for cancer diagnosis, metabolic phenotyping, and characterization of tumor microenvironment.
He Q; Xu RZ; Shkarin P; Pizzorno G; Lee-French CH; Rothman DL; Shungu DC; Shim H
Dis Markers; 2003-2004; 19(2-3):69-94. PubMed ID: 15096706
[TBL] [Abstract][Full Text] [Related]
12. Integration of MRI and MRS approaches to monitor molecular imaging and metabolomic effects of trabectedin on a preclinical ovarian cancer model.
Canese R; Palombelli G; Chirico M; Sestili P; Bagnoli M; Canevari S; Mezzanzanica D; Podo F; Iorio E
NMR Biomed; 2019 Oct; 32(10):e4016. PubMed ID: 30375088
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
[TBL] [Abstract][Full Text] [Related]
14.
Bednarik P; Goranovic D; Svatkova A; Niess F; Hingerl L; Strasser B; Deelchand DK; Spurny-Dworak B; Krssak M; Trattnig S; Hangel G; Scherer T; Lanzenberger R; Bogner W
Nat Biomed Eng; 2023 Aug; 7(8):1001-1013. PubMed ID: 37106154
[TBL] [Abstract][Full Text] [Related]
15. Deuterium MRSI characterizations of glucose metabolism in orthotopic pancreatic cancer mouse models.
Markovic S; Roussel T; Agemy L; Sasson K; Preise D; Scherz A; Frydman L
NMR Biomed; 2021 Sep; 34(9):e4569. PubMed ID: 34137085
[TBL] [Abstract][Full Text] [Related]
16. 31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.
Klomp DW; van de Bank BL; Raaijmakers A; Korteweg MA; Possanzini C; Boer VO; van de Berg CA; van de Bosch MA; Luijten PR
NMR Biomed; 2011 Dec; 24(10):1337-42. PubMed ID: 21433156
[TBL] [Abstract][Full Text] [Related]
17. Comparison of reproducibility of single voxel spectroscopy and whole-brain magnetic resonance spectroscopy imaging at 3T.
Zhang Y; Taub E; Salibi N; Uswatte G; Maudsley AA; Sheriff S; Womble B; Mark VW; Knight DC
NMR Biomed; 2018 Apr; 31(4):e3898. PubMed ID: 29436038
[TBL] [Abstract][Full Text] [Related]
18. In vivo ³¹P magnetic resonance spectroscopic imaging (MRSI) for metabolic profiling of human breast cancer xenografts.
Esmaeili M; Moestue SA; Hamans BC; Veltien A; Kristian A; Engebråten O; Maelandsmo GM; Gribbestad IS; Bathen TF; Heerschap A
J Magn Reson Imaging; 2015 Mar; 41(3):601-9. PubMed ID: 24532410
[TBL] [Abstract][Full Text] [Related]
19. MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.
Najac C; Ronen SM
Top Magn Reson Imaging; 2016 Oct; 25(5):187-196. PubMed ID: 27748711
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic targets and biomarkers identified in cancer choline phospholipid metabolism.
Glunde K; Serkova NJ
Pharmacogenomics; 2006 Oct; 7(7):1109-23. PubMed ID: 17054420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
